BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 14, 2005
View Archived Issues
Schering-Plough highlights first quarter developments
Read More
G-207 studied in malignant glioma
Read More
NX-1207 shows long-term efficacy in improving the symptoms of BPH
Read More
Phase II study investigates ginger for CINV
Read More
Dosing begins in phase I trial of Hedgehog antagonist for basal cell carcinoma
Read More
Harnal D launched in Japan
Read More
Chugai subsidiary renamed
Read More
FDA extends action date for SomatoKine NDA
Read More
MicroRNAs: potential novel human oncogenes
Read More
Further study required for Sativex approval in U.K.
Read More
IPI-504 studied in relapsed and relapsed refractory multiple myeloma
Read More
Spotlight on PTSD
Read More
Phase I results discussed for Sinovac's SARS vaccine
Read More
Fast track designation for Laszarin for heart failure in diabetes patients
Read More
NIP-004: Novel thrombopoietin mimetic small-molecule compound
Read More
Combi-molecule targets Bcr-Abl kinase and damages DNA
Read More
Lyrica approved as add-on treatment for partial onset seizures
Read More
Zmax single-dose antibiotic receives FDA approval
Read More
Long-term effects reported for febuxostat in hyperuricemia and gout
Read More
Clazosentan acts as a potent competitive ETA receptor antagonist
Read More
NVP-AEW-541 studied for treatment of musculoskeletal tumors
Read More
Recent patent discloses novel immunosuppressive agents
Read More
Iloprost and bosentan reduce mortality in PPH patients waiting for a transplant
Read More
Novel therapeutics for cardiovascular diseases reported in recent patents
Read More
Potassium channel blockers for glaucoma, etc., emerge from Merck & Co. research
Read More
MCI-196 decreases serum phosphate and cholesterol levels of hemodialysis patients
Read More
